Skip to content
10-Q

Quarterly Report

Gala Pharmaceutical Inc.

0001683168-19-002291

← back to feed
Filed
Jul 23, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2019 · Jul 19, 2019 118.02M sh
Capex Q2 2019 · May 31, 2019 $270.93K
Capex Q2 2019 · May 31, 2018 $0
Operating Cash Flow Q2 2019 · May 31, 2019 −$206.73K
Operating Cash Flow Q2 2019 · May 31, 2018 −$243.59K
Stockholders Equity Q2 2019 · May 31, 2019 −$2.99M
Stockholders Equity Q2 2019 · Nov 30, 2018 −$811.23K
Total Liabilities Q2 2019 · May 31, 2019 $3.46M
Total Liabilities Q2 2019 · Nov 30, 2018 $1.12M
Current Assets Q2 2019 · May 31, 2019 $93.05K
Current Assets Q2 2019 · Nov 30, 2018 $227K
Total Assets Q2 2019 · May 31, 2019 $385.6K
Total Assets Q2 2019 · Nov 30, 2018 $262.16K
Sga Expense Q2 2019 · May 31, 2019 $76.89K
Sga Expense Q2 2019 · May 31, 2019 $115.56K
Sga Expense Q2 2019 · May 31, 2018 $109.07K
Sga Expense Q2 2019 · May 31, 2018 $145.33K
Net Income Q2 2019 · May 31, 2019 −$2.11M
Net Income Q2 2019 · May 31, 2019 −$2.69M
Net Income Q2 2019 · May 31, 2018 −$393.75K
Net Income Q2 2019 · May 31, 2018 −$976.99K
Gross Profit Q2 2019 · May 31, 2019 $0
Gross Profit Q2 2019 · May 31, 2019 $0
Gross Profit Q2 2019 · May 31, 2018 $1.46K
Gross Profit Q2 2019 · May 31, 2018 $1.46K
Cost Of Revenue Q2 2019 · May 31, 2019 $0
Cost Of Revenue Q2 2019 · May 31, 2019 $0
Cost Of Revenue Q2 2019 · May 31, 2018 $3.22K
Cost Of Revenue Q2 2019 · May 31, 2018 $3.22K
Revenue Q2 2019 · May 31, 2019 $0
Revenue Q2 2019 · May 31, 2019 $0
Revenue Q2 2019 · May 31, 2018 $4.68K
Revenue Q2 2019 · May 31, 2018 $4.68K